These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice. Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Brånén L; Hovgaard L; Nitulescu M; Bengtsson E; Nilsson J; Jovinge S Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2137-42. PubMed ID: 15345516 [TBL] [Abstract][Full Text] [Related]
4. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. van Vlijmen BJ; van den Maagdenberg AM; Gijbels MJ; van der Boom H; HogenEsch H; Frants RR; Hofker MH; Havekes LM J Clin Invest; 1994 Apr; 93(4):1403-10. PubMed ID: 8163645 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of fibrinogen in ApoE*3-Leiden transgenic mice does not influence the progression of diet-induced atherosclerosis. Rezaee F; Gijbels MJ; Offerman EH; van der Linden M; De Maat MP; Verheijen JH Thromb Haemost; 2002 Aug; 88(2):329-34. PubMed ID: 12195708 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Chi H; Messas E; Levine RA; Graves DT; Amar S Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494 [TBL] [Abstract][Full Text] [Related]
7. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development. Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice. Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241 [TBL] [Abstract][Full Text] [Related]
9. Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol. Kooistra T; Verschuren L; de Vries-van der Weij J; Koenig W; Toet K; Princen HM; Kleemann R Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2322-30. PubMed ID: 16873727 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123 [TBL] [Abstract][Full Text] [Related]
12. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice. Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561 [TBL] [Abstract][Full Text] [Related]
13. Absence of an atheroprotective effect of the garlic powder printanor in APOE*3-Leiden transgenic mice. Espirito Santo SM; van Vlijmen BJ; van Duyvenvoorde W; Offerman EH; Havekes LM; Arnault I; Auger J; Princen HM Atherosclerosis; 2004 Dec; 177(2):291-7. PubMed ID: 15530902 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels. Raffai RL; Loeb SM; Weisgraber KH Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220 [TBL] [Abstract][Full Text] [Related]
15. Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha. Canault M; Peiretti F; Poggi M; Mueller C; Kopp F; Bonardo B; Bastelica D; Nicolay A; Alessi MC; Nalbone G J Pathol; 2008 Apr; 214(5):574-83. PubMed ID: 18247429 [TBL] [Abstract][Full Text] [Related]
16. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice. Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130 [TBL] [Abstract][Full Text] [Related]
17. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564 [TBL] [Abstract][Full Text] [Related]
18. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation. Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266 [TBL] [Abstract][Full Text] [Related]
19. ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5. Patel S; Thelander EM; Hernandez M; Montenegro J; Hassing H; Burton C; Mundt S; Hermanowski-Vosatka A; Wright SD; Chao YS; Detmers PA Biochem Biophys Res Commun; 2001 Aug; 286(1):164-70. PubMed ID: 11485323 [TBL] [Abstract][Full Text] [Related]
20. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice. Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]